Neo Ivy Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,104
| Closed | -$2.65M | – | 393 |
|
|
2025
Q1 | $2.65M | Buy |
6,104
+5,129
| +526% | +$2.23M | 0.85% | 24 |
|
|
2024
Q4 | $359K | Buy |
+975
| New | +$359K | 0.07% | 196 |
|
|
2023
Q4 | $715K | Buy |
+1,516
| New | +$715K | 1.6% | 18 |
|
|
2023
Q3 | – | Sell |
-6,411
| Closed | -$2.85M | – | 358 |
|
|
2023
Q2 | $2.85M | Buy |
+6,411
| New | +$2.85M | 1.5% | 11 |
|
|
2022
Q1 | – | Sell |
-19
| Closed | -$9K | – | 513 |
|
|
2021
Q4 | $9K | Sell |
19
-579
| -97% | -$274K | 0.01% | 386 |
|
|
2021
Q3 | $157K | Sell |
598
-85
| -12% | -$22.3K | 0.18% | 181 |
|
|
2021
Q2 | $261K | Buy |
+683
| New | +$261K | 0.26% | 139 |
|
|
2020
Q3 | – | Sell |
-598
| Closed | -$157K | – | 496 |
|
|
2020
Q2 | $157K | Sell |
598
-219
| -27% | -$57.5K | 0.18% | 181 |
|
|
2020
Q1 | $185K | Buy |
817
+801
| +5,006% | +$181K | 0.3% | 125 |
|
|
2019
Q4 | $5K | Buy |
+16
| New | +$5K | 0.01% | 238 |
|
|
2019
Q2 | – | Sell |
-1,639
| Closed | -$470K | – | 310 |
|
|
2019
Q1 | $470K | Buy |
+1,639
| New | +$470K | 0.27% | 154 |
|